Description: BioCube, Inc. is a biotechnology company that seeks to identify, mentor and facilitate the development of technologies, products and services for medical and biological applications. The Company's products and services include CannaSens Delta9, American Cannabis and Canadian Cannabis. The Company's Delta9 utilizes ion mobility spectrometry (IMS), photoionization detector (PID) or gas chromatography (GC)-column detection technologies to analyze the breath sample collected from an individual exhaling into a tube attached to the device. The Company's Delta9 characteristics include real-time analysis, direct analysis without the use of other devices and managing operating cost. The CannaSens Delta9 is a device that can detect the presence of tetrahydrocannabinol (THC) in the breath of an individual having smoked marijuana within various hours to being tested. The Company's American Cannabis offers information on medical marijuana.
1531 Smithtown Avenue
Bohemia,
NY
11716
United States
Phone:
888-827-7901
Officers
| Name | Title |
|---|---|
| Mr. Paul Lisak M.S., R.E.H.S. | Chairman, Chief Executive Officer and Chief Financial Officer |
Exchange: PINK
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Financials |
|---|---|
| GIC Group: | Financial Services |
| GIC Industry: | Capital Markets |
| GIC Sub-Industry: | Asset Management & Custody Banks |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0.0018 |
| IPO Date: | |
| Fiscal Year End: | January |
| Full Time Employees: | 0 |